MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models

Dedifferentiated liposarcoma (DDLPS) is an aggressive mesenchymal cancer marked by amplification of MDM2, an inhibitor of the tumor suppressor TP53. DDLPS patients with higher MDM2 amplification have lower chemotherapy sensitivity and worse outcome than patients with lower MDM2 amplification. We hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Patt, Andrew, Demoret, Bryce, Stets, Colin, Bill, Kate-Lynn, Smith, Philip, Vijay, Anitha, Patterson, Andrew, Hays, John, Hoang, Mindy, Chen, James L., Mathé, Ewy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463633/
https://www.ncbi.nlm.nih.gov/pubmed/32759684
http://dx.doi.org/10.3390/cancers12082157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463633/
https://www.ncbi.nlm.nih.gov/pubmed/32759684
http://dx.doi.org/10.3390/cancers12082157

Ejemplares similares